20 Aug 2026
Design, synthesis, antiproliferative evaluation, and computational study of quinoline-based analogs for EGFR and VEGFR-2 inhibitionPublisher siteJournal of Molecular Structure, HER2/EGFR in Cancer Research
UniversitiesMohamed Ayman El‐Zahabi
Active, last published 2026
In quinazolinone synthesis and applications
Mohamed Ayman
El‐Zahabi
Scholar“Research focused on Quinazolinone synthesis and applications and adjacent fields.”
Al-Azhar University
Claim Your Profile17
H-index
1.1k
Citations
Mohamed has not officially claimed their profile. If you are Mohamed, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
ohamed Ayman El‐Zahabi is a researcher working on Quinazolinone synthesis and applications. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Mohamed's work has been cited 1,052 times across 4 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
Quinazolinone synthesis and applications×18Cancer therapeutics and mechanisms×11Angiogenesis and VEGF in Cancer×10Protein Degradation and Inhibitors×10Synthesis and biological activity×9
04 · Where I am
Affiliations
Affiliation on published researchAl-Azhar UniversityDrawn from the institution listed on this researcher’s published work.
Research themes (UN SDGs)
05 · Selected work
Recent publications
7 works25 Apr 2026
Quinoxaline-based scaffolds as dual VEGFR-2/EGFR kinase inhibitors and apoptotic inducers: Design, synthesis, anticancer evaluation, and in silico studyPublisher siteBioorganic Chemistry, Synthesis and Biological Evaluation
25 Mar 2026
Design, synthesis, and in silico study of VEGFR-2 and HDAC dual acting quinazoline based molecules for anticancer evaluationPublisher siteBioorganic Chemistry, Histone Deacetylase Inhibitors Research
24 Sept 20254cites
Design, synthesis, anticancer evaluation, biological screening, and computational study of novel 6,7-dimethoxyquinazoline derivatives as VEGFR-2 inhibitors and apoptotic inducersPublisher siteEuropean Journal of Medicinal Chemistry, Synthesis and biological activity
15 Dec 2023Open access12cites
New nicotinamide derivatives as potential anticancer agents targeting VEGFR-2: design, synthesis, <i>in vitro</i> , and <i>in silico</i> studiesPublisher siteJournal of Biomolecular Structure and Dynamics, Cancer Mechanisms and Therapy
21 Sept 2022Open access48cites
Discovery of New VEGFR-2 Inhibitors: Design, Synthesis, Anti-Proliferative Evaluation, Docking, and MD Simulation StudiesPublisher siteMolecules, Angiogenesis and VEGF in Cancer
16 Aug 2022Open access62cites
New quinoline and isatin derivatives as apoptotic VEGFR-2 inhibitors: design, synthesis, anti-proliferative activity, docking, ADMET, toxicity, and MD simulation studiesPublisher siteJournal of Enzyme Inhibition and Medicinal Chemistry, Cancer Mechanisms and Therapy
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Mohamed?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you